EUDA Health Holdings Ltd (EUDAW) Return on Sales (2022 - 2023)
EUDA Health Holdings' (EUDAW) quarterly Return on Sales came in at 0.46% in Q2 2023, down 45.0% year-on-year from 0.83% in Q2 2022, and down 3125.1% on a QoQ basis from 0.01% in Q1 2023.
EUDA Health Holdings Ltd (EUDAW) Return on Sales (2022 - 2023) Analysis & Trends
EUDA Health Holdings (EUDAW) has 2 years of Return on Sales data on file, last reported at 0.46% in Q2 2023.
- On a quarterly basis, Return on Sales fell 45.0% year-over-year to 0.46% in Q2 2023; TTM through Jun 2023 was 0.03%, a N/A change from a year earlier, with the FY2025 full-year figure at 0.0%, down 1.0% from the prior year.
- Return on Sales for Q2 2023 stood at 0.46%, down from 0.01% in the prior quarter.
- Over the last five years, Return on Sales for EUDAW reached as high as 0.0% in Q1 2022 and fell as low as 0.46% in Q2 2023.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -0.46% |
| Mar 31, 2023 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | 0.00% |